These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1131970)

  • 21. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Testosterone therapy versus other factors on the self-reported sexual satisfaction of premenopausal women.
    Hong L; Wu K; Fan D
    Ann Intern Med; 2008 Sep; 149(5):361; author reply 361-2. PubMed ID: 18765712
    [No Abstract]   [Full Text] [Related]  

  • 23. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction.
    Guay A; Jacobson J; Munarriz R; Traish A; Talakoub L; Quirk F; Goldstein I; Spark R
    Int J Impot Res; 2004 Apr; 16(2):121-9. PubMed ID: 14973532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study identifies effective testosterone dose for women.
    Harv Womens Health Watch; 2014 Nov; 22(3):8. PubMed ID: 26080465
    [No Abstract]   [Full Text] [Related]  

  • 26. Which Postmenopausal Women Should Use Testosterone for Low Sexual Desire?
    Slomski A
    JAMA; 2020 Feb; 323(6):493-495. PubMed ID: 31968073
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
    Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
    Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.
    Warnock JK; Bundren JC; Morris DW
    Psychopharmacol Bull; 1997; 33(4):761-6. PubMed ID: 9493489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The testosterone patch for women.
    Kingsberg SA
    Int J Impot Res; 2005; 17(5):465-6. PubMed ID: 16049522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of treatment of libido disorders in women].
    Gabele A
    Z Allgemeinmed; 1971 Apr; 47(12):666-8. PubMed ID: 5103322
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
    Barton DL; Wender DB; Sloan JA; Dalton RJ; Balcueva EP; Atherton PJ; Bernath AM; DeKrey WL; Larson T; Bearden JD; Carpenter PC; Loprinzi CL
    J Natl Cancer Inst; 2007 May; 99(9):672-9. PubMed ID: 17470735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
    Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women.
    Seidman SN
    Curr Psychiatry Rep; 2000 Jun; 2(3):215-22. PubMed ID: 11122959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA advisers to assess drug for low sexual desire in women.
    Moynihan R
    BMJ; 2010 May; 340():c2786. PubMed ID: 20501573
    [No Abstract]   [Full Text] [Related]  

  • 37. To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application.
    Raza S; Baig M; Ali J; Rizvi S
    Int J Impot Res; 2008; 20(2):226-8. PubMed ID: 17851581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Let's talk about sex--and drugs.
    Enserink M
    Science; 2005 Jun; 308(5728):1578. PubMed ID: 15947172
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative study and treatment of frigidity in women in rural and urban environment].
    Mosković S
    Srp Arh Celok Lek; 1970 Jan; 98(1):35-41. PubMed ID: 5203584
    [No Abstract]   [Full Text] [Related]  

  • 40. Female androgen insufficiency.
    Bachmann G; Oza D
    Obstet Gynecol Clin North Am; 2006 Dec; 33(4):589-98. PubMed ID: 17116503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.